Caris Life Sciences® is at the intersection of science, medicine and information – delivering invaluable solutions to biopharma companies and researchers developing the next generation of oncology precision medicines.
Designed to maximize the chances of success for clinical trials and address many patient accrual challenges facing biopharma partners in the world of precision medicine.
Our data-driven, molecular insights are changing the landscape of precision medicine with actionable insights from retrospective, epidemiologic, and real-time molecular data to enhance research and commercial activities.
At our 66,000 square foot, state-of-the-art laboratory located in Phoenix, Arizona, we provide high quality, reliable molecular testing services for all stages of the drug development cycle and routine clinical use.
Right-In-Time (RIT) research is a rapid start-up/enrollment process where research sites screen for patients prior to activation. Using the RIT approach, Caris Trial Solutions can activate research sites on clinical trials within 10-14 days. The purpose of the program is to reduce the burden on research facilities, which allows them access to a larger number of potential trials when they have an eligible patient. This allows physicians at Caris RIT sites to include clinical trials, not yet opened, in their treatment options for current and future patients.
We offer unparalleled precision medicine services designed to maximize the chances of success and address many patient accrual challenges.